Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
Fujian Zitian Media Technology
300280
SigmaStar Technology
301536
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -48.22%248.44M | 2.97%321.08M | -37.02%374.82M | -19.19%510.24M | 3.75%479.82M | -69.09%311.82M | 84.72%595.1M | 48.10%631.39M | 15.90%462.45M | 88.57%1.01B |
Transactional financial assets | --70.12M | ---- | --100.15M | --100.21M | ---- | ---- | ---- | ---- | --1.96M | ---- |
Notes receivable and accounts receivable | -51.47%1.48B | -33.74%1.72B | -20.39%2.19B | -20.51%2.35B | 5.25%3.05B | -7.08%2.6B | 12.98%2.76B | 55.32%2.95B | 112.58%2.9B | 150.69%2.8B |
-Notes receivable | -66.55%494.74M | -50.41%716.94M | 1.62%1.05B | -26.77%1.07B | 6.61%1.48B | 19.96%1.45B | -24.51%1.04B | 80.36%1.47B | 114.81%1.39B | 80.23%1.21B |
-Accounts receivable | -37.25%984.17M | -12.94%1.01B | -33.65%1.14B | -14.34%1.27B | 4.00%1.57B | -27.48%1.16B | 61.20%1.72B | 36.60%1.49B | 110.57%1.51B | 255.62%1.6B |
Other receivables (including interest and dividends) | -57.15%3.34M | -78.71%2.64M | -62.66%4.22M | 64.61%16.25M | -57.29%7.78M | -12.83%12.41M | -46.02%11.3M | -50.06%9.87M | 89.23%18.23M | -26.93%14.23M |
-Other receivable | ---- | -78.71%2.64M | ---- | 64.61%16.25M | ---- | -12.83%12.41M | ---- | 59.75%9.87M | ---- | -26.93%14.23M |
Advance payment | -70.02%93.62M | -46.79%135.87M | -36.54%155.46M | -64.61%38.39M | -14.18%312.32M | -52.52%255.36M | -11.77%244.96M | 33.36%108.48M | 65.05%363.94M | 859.58%537.84M |
Inventories | -74.94%239.14M | -64.26%407.8M | -52.81%638.03M | -44.98%729.15M | -30.01%954.13M | 48.30%1.14B | 213.77%1.35B | 274.86%1.33B | 350.21%1.36B | 156.10%769.51M |
Receivable financing | -64.68%60.18M | -54.20%77.04M | -54.09%157.77M | -70.20%61.23M | 19.79%170.38M | -12.19%168.22M | 81.55%343.62M | 10.07%205.48M | -24.28%142.23M | -37.18%191.58M |
Assets held for sale | ---- | ---- | ---- | ---- | --38.96M | ---- | ---- | ---- | ---- | ---- |
Non-current assets due within one year | --875.02K | --917.52K | --917.52K | --1.47M | ---- | ---- | ---- | ---- | --150K | --550K |
Other current assets | -47.82%83.24M | -48.74%100.34M | -39.17%137.13M | -10.38%169.63M | 9.70%159.54M | 313.60%195.75M | 560.07%225.44M | 359.05%189.28M | 154.94%145.44M | -14.88%47.33M |
Total current assets | -55.94%2.28B | -40.90%2.77B | -31.94%3.76B | -26.72%3.97B | -4.13%5.17B | -12.72%4.69B | 48.78%5.53B | 80.08%5.42B | 112.42%5.39B | 124.83%5.37B |
Non Current assets | ||||||||||
Fixed assets | ---- | 5.11%721.98M | ---- | 59.62%731.92M | ---- | 81.81%686.9M | ---- | 35.94%458.54M | ---- | 85.32%377.81M |
Constru in process | ---- | 93.04%174.56M | ---- | -27.90%107.21M | ---- | 173.18%90.43M | ---- | 427.12%148.69M | ---- | 116.25%33.1M |
Construction materials | ---- | -1.97%886.76K | ---- | 0.00%902.69K | ---- | 0.21%904.58K | ---- | 0.00%902.69K | ---- | -16.24%902.69K |
Intangible assets | 62.46%119.3M | 63.31%120.84M | 62.93%121.48M | 154.37%122.35M | 116.60%73.43M | 116.81%74M | 117.01%74.56M | 39.09%48.1M | -2.61%33.9M | -2.59%34.13M |
Long deferred expense | 35.14%153.55M | 6.63%119.56M | 11.74%124.57M | 38.83%136.48M | 36.64%113.62M | 80.82%112.13M | 74.46%111.49M | 71.38%98.31M | 107.10%83.15M | 214.87%62.01M |
Deferred tax assets | 80.52%162.62M | 142.82%167.14M | 191.71%133.42M | 197.43%124.31M | 551.61%90.08M | 383.12%68.83M | 402.50%45.74M | 219.05%41.8M | 16.66%13.82M | -3.64%14.25M |
Usufruct assets | -40.63%76.24M | -16.08%80.12M | 15.36%115.74M | 12.61%121.38M | 4.90%128.42M | -17.24%95.47M | -10.45%100.33M | 8.51%107.78M | 308.76%122.42M | 263.24%115.36M |
Other non current assets | -61.83%31.78M | -29.75%33.04M | 17.41%68.19M | -44.84%64.46M | -31.34%83.26M | -64.88%47.03M | -57.37%58.08M | 76.75%116.85M | 39.45%121.27M | 82.83%133.92M |
Total non current assets | 6.20%1.4B | 16.75%1.42B | 19.14%1.42B | 33.63%1.41B | 49.42%1.32B | 51.07%1.21B | 59.83%1.19B | 59.40%1.05B | 68.77%884.1M | 88.22%804.05M |
Total assets | -43.30%3.68B | -29.04%4.19B | -22.87%5.19B | -16.89%5.38B | 3.41%6.49B | -4.42%5.9B | 50.63%6.72B | 76.35%6.48B | 104.95%6.28B | 119.28%6.18B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -82.54%446.25M | -61.97%767.67M | -48.98%1.33B | -48.28%1.32B | 24.86%2.56B | -11.08%2.02B | 95.60%2.61B | 223.52%2.55B | 369.41%2.05B | 995.50%2.27B |
Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --980.03K | ---- | ---- | ---- |
Notes payable and accounts payable | -57.77%179.97M | -61.00%184.15M | -49.04%309.38M | -40.07%310.34M | -31.70%426.12M | 41.37%472.12M | 43.98%607.07M | 48.18%517.82M | 107.58%623.9M | 51.45%333.95M |
-Notes payable | -84.92%27.81M | -87.94%32.3M | -74.08%68.99M | -76.32%43.71M | 13.24%184.45M | 207.14%267.78M | 378.14%266.14M | 96.30%184.54M | 263.36%162.88M | 3.20%87.19M |
-Accounts payable | -37.04%152.16M | -25.69%151.85M | -29.49%240.39M | -20.00%266.64M | -47.58%241.67M | -17.19%204.35M | -6.84%340.93M | 30.47%333.28M | 80.28%461.02M | 81.41%246.77M |
Contract liabilities | -82.48%3.42M | -59.73%3.62M | -66.06%6.99M | -50.21%4.62M | 5.70%19.53M | -49.40%9M | -71.69%20.59M | 364.27%9.27M | 52.18%18.48M | -4.81%17.79M |
Salaries payable | -21.74%11.47M | -30.50%11.18M | -26.05%12.49M | -18.29%20.81M | -33.15%14.66M | -9.80%16.09M | 4.15%16.88M | 36.00%25.47M | 157.86%21.93M | 133.62%17.84M |
Taxs payable | -75.87%2.71M | 6.25%2.07M | -75.49%2.73M | -83.33%2.33M | -17.06%11.23M | -93.95%1.94M | -14.40%11.13M | -1.49%14M | 181.00%13.54M | 1,200.23%32.12M |
Other payable (including interest and dividends) | 5.67%2.94M | -42.16%2.91M | -16.12%2.84M | 101.39%4.43M | 156.76%2.78M | 53.06%5.03M | 379.69%3.38M | 172.46%2.2M | -40.96%1.08M | -92.87%3.29M |
-Other payable | ---- | -42.16%2.91M | ---- | 101.39%4.43M | ---- | 53.06%5.03M | ---- | 172.46%2.2M | ---- | 578.21%3.29M |
Non current liabilities due within one year | 474.32%187.61M | 710.25%300.21M | 704.22%160.02M | 1,395.07%372.79M | 235.83%32.67M | 142.60%37.05M | -4.13%19.9M | -5.13%24.93M | --9.73M | 334.08%15.27M |
Other current liabilities | -45.32%134.33M | -30.32%97.5M | 56.50%241.1M | -16.68%195.79M | -28.73%245.69M | -40.28%139.93M | 52.38%154.06M | 144.76%234.99M | 287.09%344.73M | 85.47%234.31M |
Total current liabilities | -70.73%968.71M | -49.28%1.37B | -39.97%2.07B | -33.99%2.23B | 7.41%3.31B | -7.69%2.7B | 73.88%3.44B | 160.72%3.38B | 261.14%3.08B | 362.40%2.92B |
Current liabilities | ||||||||||
Bonds payable | 6.05%590.64M | 6.06%581.02M | 6.13%573.54M | 6.11%564.57M | 6.16%556.96M | 6.16%547.84M | --540.41M | --532.07M | --524.63M | --516.04M |
Long term salaries pay | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -52.35%6.17M | -51.15%6.67M |
Deferred tax liabilities | ---- | -99.34%772.66 | 247.76%78K | 247.76%78K | --116.5K | --116.5K | --22.43K | --22.43K | ---- | ---- |
Long term deferred income | --13.61M | --13.61M | --13.61M | --13.61M | ---- | ---- | ---- | ---- | ---- | ---- |
Lease liabilities | -33.36%74.87M | -12.84%70.9M | 22.75%105.7M | 18.41%104M | 11.42%112.36M | -8.69%81.35M | -3.76%86.11M | 42.44%87.83M | 402.93%100.84M | 293.76%89.09M |
Total non current liabilities | -1.59%791.62M | 2.78%785.54M | 23.43%958.65M | 54.25%956.22M | 27.36%804.44M | 24.93%764.3M | 707.15%776.7M | 761.82%619.92M | 1,718.56%631.63M | 1,123.59%611.8M |
Total liabilities | -57.21%1.76B | -37.79%2.15B | -28.30%3.02B | -20.30%3.18B | 10.80%4.11B | -2.05%3.46B | 103.24%4.22B | 192.35%4B | 318.16%3.71B | 418.16%3.54B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M | 0.00%84.02M |
Other equity instruments | 0.00%176.04M | 0.00%176.04M | -0.00%176.04M | -0.01%176.04M | -0.01%176.04M | -0.01%176.04M | --176.04M | --176.05M | --176.05M | --176.05M |
Capital reserve funds | -0.02%1.62B | -0.02%1.62B | -0.02%1.62B | -0.02%1.62B | -0.00%1.62B | 0.00%1.62B | 0.01%1.62B | 0.01%1.62B | -0.01%1.62B | -0.01%1.62B |
Surplus reserve funds | 0.00%42.01M | 0.00%42.01M | 0.00%42.01M | 0.00%42.01M | 0.00%42.01M | 0.00%42.01M | 0.00%42.01M | 0.00%42.01M | 33.34%42.01M | 33.34%42.01M |
Retained profit | -85.42%68.59M | -65.02%178.97M | -48.44%298.34M | -42.94%317.18M | -26.35%470.44M | -28.30%511.59M | -9.28%578.58M | -0.15%555.83M | 46.68%638.79M | 80.89%713.48M |
Less:Treasury stock | 254.99%71M | --70.66M | --63.79M | --44.81M | --20M | ---- | ---- | ---- | ---- | ---- |
Other composite income | -257.47%-2.47M | -90.07%162.76K | --504.78K | --501.64K | --1.57M | --1.64M | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | -19.23%1.92B | -16.61%2.03B | -13.73%2.16B | -11.42%2.2B | -7.28%2.38B | -7.59%2.44B | 4.90%2.5B | 7.60%2.48B | 17.92%2.56B | 23.69%2.64B |
Total shareholder equity | -19.23%1.92B | -16.61%2.03B | -13.73%2.16B | -11.42%2.2B | -7.28%2.38B | -7.59%2.44B | 4.90%2.5B | 7.60%2.48B | 17.92%2.56B | 23.69%2.64B |
Total liabilityies and equity | -43.30%3.68B | -29.04%4.19B | -22.87%5.19B | -16.89%5.38B | 3.41%6.49B | -4.42%5.9B | 50.63%6.72B | 76.35%6.48B | 104.95%6.28B | 119.28%6.18B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.